BML Investment Partners, L.P.

13D and 13G Filings

13D/G filings
13D on 9 securities, 13G on 17 securities
CIK
0001373604
All SEC filings
View on sec.gov
Issuer % of Class Filed
LENZ Therapeutics, Inc. 13G
LENZ · 52635N103
 6.7% 11/4/2026
Event 11/2/2026
Seer, Inc. 13D
SEER · 81578P106
 4.7% 11/2/2026
Event 11/2/2026
Connect Biopharma Holdings Ltd 13G
CNTB · G23549101
 6.8% 10/6/2026
Event 9/30/2026
Outset Medical, Inc. 13G/A Amendment 4
OM · 690145206
 14.7% 10/6/2026
Event 10/2/2026
Oramed Pharmaceuticals Inc. 13G/A Amendment 3
ORMP · 68403P203
 2.5% 6/29/2026
Event 6/26/2026
Outset Medical, Inc. 13G/A Amendment 3
OM · 690145206
 13.6% 5/18/2026
Event 5/15/2026
enGene Holdings Inc. 13G/A Amendment 1
ENGN · 29286M105
 10.0% 5/14/2026
Event 5/12/2026
enGene Holdings Inc. 13G
ENGN · 29286M105
 7.8% 5/13/2026
Event 5/8/2026
Kezar Life Sciences, Inc. 13G/A Amendment 3
KZR · 49372L100
 0% 5/12/2026
Event 5/11/2026
Outset Medical, Inc. 13G/A Amendment 2
OM · 690145206
 11.8% 5/12/2026
Event 5/11/2026
Aclaris Therapeutics, Inc. 13G/A Amendment 5
ACRS · 00461U105
 9.9% 4/27/2026
Event 4/23/2026
Tilly's, Inc. 13G
TLYS · 886885102
 9.4% 3/19/2026
Event 3/12/2026
Outset Medical, Inc. 13G/A Amendment 1
OM · 690145206
 10.5% 2/13/2026
Event 2/12/2026
Kezar Life Sciences, Inc. 13G/A Amendment 2
KZR · 49372L100
 9.8% 2/9/2026
Event 12/31/2025
Instil Bio, Inc. 13G/A Amendment 2
TIL · 45783C101
 9.5% 2/9/2026
Event 12/31/2025
PMV Pharmaceuticals, Inc. 13G/A Amendment 3
PMVP · 69353Y103
 9.9% 2/9/2026
Event 12/31/2025
Oramed Pharmaceuticals Inc. 13G/A Amendment 2
ORMP · 68403P203
 8.3% 2/9/2026
Event 12/31/2025
Atea Pharmaceuticals, Inc. 13G
AVIR · 04683R106
 9.9% 2/9/2026
Event 12/31/2025
Aclaris Therapeutics, Inc. 13G/A Amendment 4
ACRS · 00461U105
 11.9% 2/9/2026
Event 12/31/2025
Outset Medical, Inc. 13G
OM · 690145206
 9.4% 1/14/2026
Event 1/12/2026
Athira Pharma Inc. 13G/A Amendment 3
ATHA · 04746L104
 0% 12/18/2025
Event 12/18/2025
Adverum Biotechnologies, Inc. 13D/A Amendment 3
ADVM · 00773U108
 0% 12/9/2025
Event 12/9/2025
Adverum Biotechnologies, Inc. 13D/A Amendment 2
ADVM · 00773U108
 9.7% 12/5/2025
Event 12/4/2025
Adverum Biotechnologies, Inc. 13D/A Amendment 1
ADVM · 00773U108
 15.6% 11/10/2025
Event 11/10/2025
Astrotech Corporation 13D/A Amendment 1
ASTC · 046484309
 0% 10/7/2025
Event 10/3/2025
Elevation Oncology, Inc. 13D/A Amendment 1
ELEV · 28623U101
 0% 7/28/2025
Event 7/23/2025
Ikena Oncology, Inc. 13D/A Amendment 1
IMA · 45175G207
 1.9% 7/28/2025
Event 7/25/2025
AN2 Therapeutics, Inc. 13D/A Amendment 2
ANTX · 037326105
 1.4% 6/18/2025
Event 6/17/2025
Ikena Oncology, Inc. 13D
IKNA · 45175G108
 8.5% 6/16/2025
Event 6/16/2025
AN2 Therapeutics, Inc. 13D/A Amendment 1
ANTX · 037326105
 10.7% 5/30/2025
Event 5/28/2025
Adverum Biotechnologies, Inc. 13D
ADVM · 00773U108
 15.6% 5/20/2025
Event 5/19/2025
AN2 Therapeutics, Inc. 13D
ANTX · 037326105
 19.1% 5/7/2025
Event 5/7/2025
Adverum Biotechnologies, Inc. 13G/A Amendment 5
ADVM · 00773U108
 13.8% 5/6/2025
Event 3/31/2025
ESSA Pharma Inc. 13D
EPIX · 29668H708
 9.5% 4/24/2025
Event 4/24/2025
Elevation Oncology, Inc. 13D
ELEV · 28623U101
 9.9% 4/16/2025
Event 4/16/2025
Elevation Oncology, Inc. 13G
ELEV · 28623U101
 9.9% 3/26/2025
Event 3/21/2025
Kezar Life Sciences, Inc. 13G
KZR · 49372L100
 5.1% 3/6/2025
Event 2/28/2025
Aadi Bioscience, Inc. 13D/A Amendment 4
WHWK · 00032Q104
 4.98% 3/5/2025
Event 3/5/2025
LAVA Therapeutics N.V. 13G
LVTX · N51517105
 7.4% 3/3/2025
Event 2/26/2025
Aadi Bioscience, Inc. 13D/A Amendment 3
WHWK · 00032Q104
 9.9% 2/24/2025
Event 2/24/2025
Third Harmonic Bio, Inc. 13G
THRD · 88427A107
 8.2% 2/14/2025
Event 2/11/2025
Ikena Oncology, Inc. 13G/A Amendment 1
IKNA · 45175G108
 7.6% 2/14/2025
Event 12/31/2024
ESSA Pharma Inc. 13G/A Amendment 1
EPIX · 29668H708
 9.5% 2/14/2025
Event 12/31/2024
Athira Pharma Inc. 13G/A Amendment 2
ATHA · 04746L104
 7.8% 2/14/2025
Event 12/31/2024
PMV Pharmaceuticals, Inc. 13G/A Amendment 2
PMVP · 69353Y103
 6.7% 2/14/2025
Event 12/31/2024
PMV Pharmaceuticals, Inc. 13G/A Amendment 1
PMVP · 69353Y103
 6.3% 2/14/2025
Event 12/31/2024
Athira Pharma Inc. 13G/A Amendment 1
ATHA · 04746L104
 6.5% 2/14/2025
Event 12/31/2024
ESSA Pharma Inc. 13G/A Amendment 1
EPIX · 29668H708
 9.4% 2/14/2025
Event 12/31/2024
Achilles Therapeutics plc 13G/A Amendment 1
ACHL · 00449L102
 10.0% 2/13/2025
Event 12/31/2024
Oramed Pharmaceuticals Inc. 13G/A Amendment 1
ORMP · 68403P203
 6.6% 2/13/2025
Event 12/31/2024
AN2 Therapeutics, Inc. 13G/A Amendment 2
ANTX · 037326105
 19.2% 2/13/2025
Event 12/31/2024
Instil Bio, Inc. 13G/A Amendment 1
TIL · 45783C101
 6.7% 2/13/2025
Event 12/31/2024
Climb Bio, Inc. 13G/A Amendment 3
CLYM · 28658R106
 0% 2/13/2025
Event 12/31/2024
Adverum Biotechnologies, Inc. 13G/A Amendment 4
ADVM · 00773U108
 11.4% 2/13/2025
Event 12/31/2024
Tectonic Therapeutic, Inc. 13G/A Amendment 3
TECX · 878972108
 0% 2/13/2025
Event 12/31/2024
Aclaris Therapeutics, Inc. 13G/A Amendment 3
ACRS · 00461U105
 13.3% 2/13/2025
Event 12/31/2024
Aadi Bioscience, Inc. 13D/A Amendment 2
WHWK · 00032Q104
 9.9% 2/4/2025
Event 2/3/2025
Aadi Bioscience, Inc. 13D
WHWK · 00032Q104
 9.9% 1/30/2025
Event 1/30/2025
Ikena Oncology, Inc. 13G
IKNA · 45175G108
 7.6% 12/31/2024
Event 12/23/2024
Aadi Bioscience, Inc. 13D
WHWK · 00032Q104
 9.9% 12/31/2024
Event 12/31/2024
Atea Pharmaceuticals, Inc. 13D
AVIR · 04683R106
 8.5% 12/16/2024
Event 12/13/2024

Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.